Pharvaris NV (Pharvaris NV) Total Liabilities : $20.03 Mil (As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Pharvaris NV Total Liabilities?

Pharvaris NV's Total Liabilities for the quarter that ended in Mar. 2024 was $20.03 Mil.

Pharvaris NV's quarterly Total Liabilities declined from Sep. 2023 ($17.30 Mil) to Dec. 2023 ($15.97 Mil) but then increased from Dec. 2023 ($15.97 Mil) to Mar. 2024 ($20.03 Mil).

Pharvaris NV's annual Total Liabilities increased from Dec. 2021 ($8.06 Mil) to Dec. 2022 ($19.57 Mil) but then declined from Dec. 2022 ($19.57 Mil) to Dec. 2023 ($15.97 Mil).

Pharvaris NV Total Liabilities Historical Data

The historical data trend for Pharvaris NV's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pharvaris NV Total Liabilities Chart

Pharvaris NV Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

2.14

6.47

8.06

19.57

15.97

Pharvaris NV Quarterly Data
	Dec18	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															19.97	17.35	17.30	15.97	20.03

Pharvaris NV Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Pharvaris NV's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	15.924	+	(0.048	+	4.1633363423443E-17
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	15.97

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	434.781	-	418.809
	=	15.97

Pharvaris NV's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	19.953	+	(0.076	+	5.1347814888913E-16
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	0)
	=	20.03

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	410.429	-	390.401
	=	20.03

Pharvaris NV Total Liabilities Related Terms

Thank you for viewing the detailed overview of Pharvaris NV's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Pharvaris NV (Pharvaris NV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Pharvaris NV (NAS:PHVS) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

9EN:Germany

Address

Emmy Noetherweg 2, Leiden, NLD, 2333 BK

Website

https://www.pharvaris.com

Pharvaris NV is a clinical-stage company. It is focused on the discovery and development and commercialization of therapies for rare diseases with significant unmet need, initially focused on angioedema and other bradykinin-mediated diseases.